Company news
TheraCryf PLC news in 2023
TheraCryf PLC's news releases, calls and decks from 2023, newest first.
Directorate Changes
December 22, 2023
Upcoming conferences
November 13, 2023
Erasmus Medical Center begins glioblastoma studies
October 26, 2023
Authored Article Publication
October 19, 2023
Final Report from Phase 1b PK/PD study
August 15, 2023
Rule 17 Disclosure
August 3, 2023
Return of rights to Sulforadex from Juvenescence
August 2, 2023
SFX-01 radiosensitisation effect confirmed in-vivo
June 27, 2023
Notice of AGM & Posting of Annual Report
June 20, 2023
Grant Success for Glioblastoma studies
June 19, 2023
Final Results
June 7, 2023
Distribution Dates and Amounts Announced for...
May 1, 2023
Preliminary results from Phase 1b study
March 22, 2023
Price Monitoring Extension
March 16, 2023
No exposure to Silicon Valley Bank
March 13, 2023
Clinical trial update
January 25, 2023
Calls in 2023
Decks in 2023
- Evgen Pharma — Corporate Update (2023)
Corporate update · 13 slides · 2023